moclobemide has been researched along with Acute Disease in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A daily dosage of 300 mg of moclobemide and 20 mg of fluoxetine would thus appear to be comparable both in antidepressant efficacy and tolerability." | 2.67 | Moclobemide versus fluoxetine for major depressive episodes. ( Bruynooghe, F; De Cuyper, H; Demeulemeester, F; Geerts, S; Haazen, L, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lonnqvist, J | 1 |
| Sihvo, S | 1 |
| Syvälahti, E | 1 |
| Sintonen, H | 1 |
| Kiviruusu, O | 1 |
| Pitkanen, H | 1 |
| Geerts, S | 1 |
| Bruynooghe, F | 1 |
| De Cuyper, H | 1 |
| Demeulemeester, F | 1 |
| Haazen, L | 1 |
2 trials available for moclobemide and Acute Disease
| Article | Year |
|---|---|
Moclobemide and fluoxetine in the prevention of relapses following acute treatment of depression.
Topics: Acute Disease; Adult; Antidepressive Agents; Benzamides; Depressive Disorder; Dose-Response Relation | 1995 |
Moclobemide versus fluoxetine for major depressive episodes.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Doub | 1994 |